#None #Singapore #Bridge to Life #organ preservation #ILTS

Exploring Innovations in Organ Preservation at ILTS 2025

Bridge to Life™ Ltd, a prominent provider of organ preservation solutions, has announced the acceptance of nine abstracts for the upcoming International Liver Transplantation Society (ILTS) Congress, set to take place from May 28 to May 31, 2025, in Singapore. This event promises to be a pivotal gathering for professionals in the field of liver transplantation, focusing on the latest advancements in medical technologies and organ preservation techniques.

Overview of Accepted Abstracts

The list of accepted abstracts illustrates the cutting-edge research being conducted in the field. Among the presentations are:

• - The Impact of Mechanical Perfusion on Ischemia-Reperfusion Injury in Liver Transplantation: This urgent study delves into donor age effects and is presented by a team from Policlinico Universitario Fondazione Agostino Gemelli, Italy.
• - Mechanical Perfusion in Liver Transplantation: A Game Changer for Medium-Volume Centers?: Also from the Italian team, this analysis explores the applicability of mechanical perfusion technology in diverse clinical settings.
• - Utilization of HOPE Machine in Unusual Transplant Scenarios - A Case Report: Researchers from the Birmingham Children’s Hospital and Queen Elizabeth Hospital in the UK detail innovative uses of hypothermic oxygenated perfusion (HOPE).
• - Hypothermic Oxygenated Perfusion in Pediatric Liver Transplantation: Preliminary Results: This promising research from Hospital Universitario La Paz, Spain, sheds light on pediatric applications of HOPE.
• - Analyzing Recurrence Rates Post-HOPE in Hepatocellular Carcinoma Patients: Researchers from Centro Hospitalar Universitário de Coimbra, Portugal, offer insights into the long-term outcomes following HOPE treatment.

Other studies focus on the implications of HOPE technology on acute hepatic failure and the implementation of HOPE processes in tertiary hospitals, emphasizing the growing importance of this innovative method in the medical community.

Interactive Workshops and Presentations

Apart from the abstracts, Bridge to Life will host a practical workshop on hepatic mechanical perfusion on May 28, 2025. Attendees will gain firsthand experience and knowledge about the latest techniques in organ preservation, enhancing their clinical practices.

Additionally, a symposium titled ‘Expanding the Boundaries of Hypothermic Oxygenated Perfusion: Addressing Challenges and Opportunities in the Asia-Pacific Region’ will take place on May 29 at 3:00 PM (UTC+8). Esteemed speakers, including Dr. Sonal Asthana from Aster Hospitals and Dr. Andrea Schlegel from the Cleveland Clinic, will discuss the future of organ preservation technologies and their impact on the Asia-Pacific region.

About Bridge to Life Ltd

Bridge to Life™ Ltd stands out as a leader in organ preservation solutions, offering premier products such as Belzer UW®, EasiSlush®, and the VitaSmart™ hypothermic oxygenated perfusion system. With a commitment to product quality, innovation, and increased accessibility, Bridge to Life collaborates with various transplantation centers and organ procurement organizations globally, continually striving to enhance the standards of care in this vital medical field. The VitaSmart product holds the CE mark and is available in various markets outside the United States, ensuring that their groundbreaking technologies reach as many healthcare providers as possible.

In anticipation of ILTS 2025, Bridge to Life is thrilled to showcase its dedication to advancing organ preservation practices and improving patient outcomes. This congress serves as an essential platform for sharing knowledge, fostering collaboration, and addressing challenges in liver transplantation across the globe.

For more updates and in-depth information, attendees and stakeholders are encouraged to visit Bridge to Life's booth at the congress and participate in lively discussions about the future of organ transplantation.